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Abstract
Introduction: Asthma and gastroesophageal reflux disease (GERD) have been closely linked, but the
association of one with the other is not completely understood. Though GERD contributes to and exacerbates
asthma symptoms, best management has not been established. Many asthmatics have subjective and objective
findings of GERD, but the use of antireflux medication may not reduce reflux-related asthma symptoms at all.
Better management of GERD may lead to better management of GERD-induced asthma. Outcomes
presented in the review will be evaluated using GRADE to assess the quality of evidence each study provides.
Methods: Articles for this review were chosen by relevance to the search terms “asthma” and “fundoplication”.
Literature containing the relevant subject terms was evaluated, and articles were chosen for inclusion if they
specifically addressed patients who underwent fundoplication for the primary indication of asthma and/or
respiratory symptoms due to reflux disease.
Results: The studies all showed fundoplication to be superior over antacid medication of any kind. Patients
undergoing fundoplicaton showed immediate improvement and continued improvement or cure through the
course of follow-up periods. Postoperatively, most patients showed reduced asthma symptoms and required
fewer asthma control medications.
Conclusion: Nissen fundoplication cures acid reflux in 90 percent of GERD patients, whereas medical
management has only mediocre results and those results are not usually long-lived. Even though proton pump
inhibitors (PPIs) and H2 receptor antagonists (H2 blockers) reduce acid production, reflux of acid and
microaspiration of refluxate still occurs. This microaspiration continues to contribute to hypersensitivity of
the airways. With fundoplication, the pressure of the lower esophageal sphincter is restored and further reflux
is prevented, thus making fundoplication the most effective management of GERD, and of any asthma and
respiratory symptoms associated with the reflux. While fundoplication does not cure or markedly improve
every asthma symptom or pulmonary function test, these studies, assessed by GRADE criteria, provide good,
though not excellent, evidence that fundoplication should be considered for patients with GERD-induced
asthma, especially those whose symptoms interfere with daily living or those requiring use of oral
corticosteroids.
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ABSTRACT 
Introduction:  Asthma and gastroesophageal reflux disease (GERD) have been closely 
linked, but the association of one with the other is not completely understood.  Though 
GERD contributes to and exacerbates asthma symptoms, best management has not 
been established.  Many asthmatics have subjective and objective findings of GERD, 
but the use of antireflux medication may not reduce reflux-related asthma symptoms at 
all.  Better management of GERD may lead to better management of GERD-induced 
asthma.  Outcomes presented in the review will be evaluated using GRADE to assess 
the quality of evidence each study provides. 
  
Methods: Articles for this review were chosen by relevance to the search terms 
“asthma” and “fundoplication”.  Literature containing the relevant subject terms was 
evaluated, and articles were chosen for inclusion if they specifically addressed patients 
who underwent fundoplication for the primary indication of asthma and/or respiratory 
symptoms due to reflux disease.   
  
Results: The studies all showed fundoplication to be superior over antacid medication 
of any kind.  Patients undergoing fundoplicaton showed immediate improvement and 
continued improvement or cure through the course of follow-up 
periods.  Postoperatively, most patients showed reduced asthma symptoms and 
required fewer asthma control medications.   
  
Conclusion: Nissen fundoplication cures acid reflux in 90 percent of GERD patients, 
whereas medical management has only mediocre results and those results are not 
usually long-lived.  Even though proton pump inhibitors (PPIs) and H2 receptor 
antagonists (H2 blockers) reduce acid production, reflux of acid and microaspiration of 
refluxate still occurs.  This microaspiration continues to contribute to hypersensitivity of 
the airways.  With fundoplication, the pressure of the lower esophageal sphincter is 
restored and further reflux is prevented, thus making fundoplication the most effective 
management of GERD, and of any asthma and respiratory symptoms associated with 
the reflux.  While fundoplication does not cure or markedly improve every asthma 
symptom or pulmonary function test, these studies, assessed by GRADE criteria, 
provide good, though not excellent, evidence that fundoplication should be considered 
for patients with GERD-induced asthma, especially those whose symptoms interfere 
with daily living or those requiring use of oral corticosteroids.  
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INTRODUCTION 
Background 
  Asthma and gastroesophageal reflux disease (GERD) are common conditions 
affecting millions of Americans.  Asthma affects five percent of the population and its 
prevalence has increased over the past twenty years (Chesnutt, & Prendergast, 2010).  
Approximately twenty percent of the population experiences gastroesophageal reflux 
(GER) (McQuaid, 2010).  A relationship between the two has been suggested and 
studied, however, their exact correlation to one another has remained controversial and 
unclear.  It is estimated that 30 to 90 percent of those with asthma also have GER.  It is 
becoming more clear that GER triggers asthma, possibly due to microaspiration of 
reflux or activation of vagal reflexes.  The presence of acid reflux in asthmatics leads to 
poorer control of asthma and an overall reduced quality of life.   A majority of asthmatics 
who experience GER, also have objective findings, in addition to the symptomatic 
manifestations.  One particular systematic review of 28 patients with asthma found 59 
percent had reflux symptoms, 51 percent had abnormal intraesophageal pH levels, 51 
percent had hiatal hernias, and 37 percent had esophagitis (Havemann et al, 2007).  
Medical management of acid suppression with proton pump inhibitors (PPIs) and H2 
blockers, aimed at improving respiratory symptoms and reducing the need for asthma 
medication, has had varying degrees of success, ranging from no relief to complete 
suppression of reflux symptoms along with improvement of respiratory symptoms.  
Some asthma patients were able to reduce the need for control medications with 
successful acid suppression.  Surgical management, specifically Nissen fundoplication, 
appears to be the most definitive intervention for treatment of GERD, as ninety percent 
of patients reported resolution of reflux symptoms following the Nissen procedure.  
Nissen fundoplication, which has now become the surgical treatment of choice in 
controlling GERD symptoms, can essentially provide a cure for the majority of reflux 
patients.  This procedure restores a physiologic equivalent of a lower esophageal 
sphincter, which becomes incompetent in patients with GERD.  In contrast to GERD, 
asthma must be managed medically and there are no surgical interventions providing 
cure or relief.  In patients with severe enough asthma, those medications include oral 
steroids, which have adverse systemic effects, especially with chronic use.  Because 
there are better outcomes for reflux symptoms with surgical intervention, and given the 
established, albeit unclear, relationship between acid reflux and asthma symptoms, the 
use of fundoplication as an intervention for controlling respiratory symptoms and 
reducing the need for control medication should be analyzed and strongly considered.   
Determining the efficacy of surgical management with Nissen fundoplication to reduce 
or eliminate acid reflux, specifically for controlling asthma symptoms and reducing the 
need for control medication, is an important step for patients with asthma that is 
worsened by concomitant GERD. 
Purpose of Study 
 The purpose of this paper is to conduct a systematic review of the literature to 
evaluate the effectiveness of Nissen fundoplication in reducing asthma symptoms and 
the need for control medication.  These studies will also be analyzed with a GRADE 
assessment to evaluate the strength and/or weakness of the outcome. 
 
 
METHOD 
 A literature search was performed using PubMed, Medline, and SpringerLink.  
These databases were accessed through the Uniformed Services University Learning 
Resources Center Electronic Resources System.  The keywords search included 
“asthma” and “fundoplication” in combination.  The search was limited to English 
language and full text journal articles. The initial results included 244 articles.   Studies 
were sorted by relevance and reviewed for content that addressed the clinical question, 
including patients studied who had both gastroesophageal reflux and asthma and had 
undergone fundoplication to control reflux.  Two articles that addressed patients with 
both gastroesophageal reflux and asthma who underwent fundoplication were selected.   
Another article that addressed gastroesphageal reflux and associated respiratory 
symptoms, including cough and wheezing, was also selected.  Some studies looked at 
medication to control reflux in addition to fundoplication.  Articles between 1999 and 
2010 were selected. Case reviews were excluded.  After exclusion criteria were applied, 
articles were reviewed for relevancy and three were chosen to review.  
RESULTS 
 The first study reviewed was a retrospective study by Spivak et al. (1999).  In this 
study, 39 patients met their inclusion criteria, which was asthma as their primary 
indication for undergoing fundoplication.  The mean duration of asthma symptoms prior 
to surgery was fifteen years, and the mean duration of reflux symptoms was eight years.  
Sixty-four percent of these patients felt that there was a direct association between the 
two.  Mean follow-up for this study was 2.7 years.  All patients rated their asthma 
symptoms as severe and interfering with daily activities, and all patients used daily 
control medication.  Reflux symptoms of these patients were also rated as severe, and 
all patients were taking PPI or H2 blocker therapy prior to fundoplication.  Outcomes 
measured were symptoms as measured by the National Asthma Education Program, 
medication use, and pulmonary function.  Asthma symptoms, including asthma 
exacerbations, cough/wheeze, exercise tolerance, and nocturnal asthma all improved 
significantly (P<0.01).  The only symptomatic outcome that was not significant was time 
missed from work or school.  Frequency of medication use (inhaled bronchodilators, 
inhaled steroids, oral bronchodilators, and oral corticosteroids) decreased in all patients 
undergoing fundoplication, however, the only medication reduction to reach statistical 
significance was the use of oral corticosteroids (P<0.001).   Of those taking daily oral 
corticosteroid therapy, 78% discontinued use of oral steroids completely.  Pulmonary 
function tests did not see improvement postoperatively.  Of note, although exact 
numbers and percentages were not discussed, all gastroesophageal reflux symptoms 
(heartburn, regurgitation, dysphagia) and use of reflux medication, either PPIs or H2 
blockers, were reduced significantly postoperatively. The authors concluded that 
fundoplication effectively decreases asthma symptoms and allows for reduction in 
control medication, the most important of which being systemic oral steroids.  In a 
patient with steroid-dependent asthma or one without GERD medication success, 
strong consideration for surgical referral for fundoplication should be given. 
 The next study reviewed, by Sontag et al. (2003), was a long-term follow-up on a 
randomized trial of 62 patients with gastroesophageal reflux and asthma to determine 
whether prolonged treatment of GER altered the long-term natural history of asthma in 
asthmatics with GER.  Follow-up time was up to 19.1 years.  The patients were 
randomized to one of three antireflux groups; a control group to use antacids as 
needed, a medication group to use ranitidine 150 mg TID, and a surgical group who 
underwent Nissen fundoplication.  Medication and control groups were treated for a 
duration of two years.  In this trial, asthma was defined as prior diagnosis with discrete 
attacks of wheezing and 20% reversibility in airway disease, and GER was defined as 
an abnormal ambulatory 24-hour pH test and macroscopic or microscopic evidence of 
GERD.  In terms of asthma symptom scores, improvement of at least 40% from 
baseline occurred in 75% of patients in the surgical group versus 20% in the control 
group and none in the medical group.  Conversely, asthma symptoms worsened by at 
least 40% from baseline in 7% of the control group, 18% of the medical group, and none 
of the surgery group.  The difference between improved asthma symptoms in the 
medical and control group versus in the surgical group was statistically significant 
(P<0.05).  Only the surgical group reached statistically significant improvement in 
asthma symptom scores.  Peak flow rates showed immediate improvement and long-
term improvement in the surgical group, but not in either the medical or control groups.  
Although the difference between the surgical group versus the medical and control 
group appeared significant, the analyzable data was too small to demonstrate 
significance.  Overall need for asthma control medication was reduced in the surgical 
group, slightly reduced in the medical group, but not reduced in the control group.  
Bronchodilator and inhaled corticosteroid therapy was not significantly reduced in the 
surgery group, however, 25% of patients requiring daily systemic corticosteroids and 
50% of patients requiring intermittent systemic corticosteroids were able to discontinue 
corticosteroid use all together.  While the reduction of oral steroid need is noteworthy, it 
was not statistically significant. The authors of this study concluded that, while 
pulmonary function, control medication needs, and long-term survival did not 
overwhelmingly improve, overall clinical status in these patients was markedly improved 
in comparison to those patients in either the medication or control group. 
 The third study reviewed, a retrospective study by Patti et al. (2000), looked at 
the effect fundoplication had on GERD-induced respiratory symptoms.  The study 
examined the correlation and predictive values of cough associated with reflux, pH, and 
respiratory symptoms.  Thirty-nine of the 340 patients used in the study had coughing 
and wheezing associated with esophageal reflux within three minutes of reflux onset.  
Patients with cough associated with reflux (within three minutes of each other), as 
detected by pH monitoring, were most likely to benefit from antireflux surgery.  Eighty-
three percent of these patients had resolution of symptoms, compared to 57% when 
there was no correlation between cough and reflux.    Overall, 74% of these patients 
had resolution of their cough and 64% had resolution of wheezing after undergoing 
fundoplication.  This study suggested pH monitoring as the best way to predict 
postoperative resolution of respiratory symptoms.  This is particularly useful when pH is 
measured at both the lower esophageal sphincter (LES) and upper esophageal 
sphincter.  Outcomes were more dramatic when acidic pH was measured at the upper 
esophageal sphincter due to increased likelihood that respiratory symptoms were due to 
aspiration of refluxate.  Seventy-seven percent of patients had resolution of respiratory 
symptoms when acidic pH was measured in the LES alone versus 90% of patients with 
respiratory symptoms resolution when acidic pH was measure in both the distal and 
proximal esophageal sphincters.  The authors conclude that, while some patients may 
or may not respond satisfactorily to medication therapy, more patients, including those 
who do not respond well to medication, will benefit from antireflux surgery.  The 
challenge is deciphering who will benefit the most from surgery, and that surgery should 
be considered and completed before irreversible lung damage occurs.  
DISCUSSION 
 While there is still an unclear connection between GERD and asthma, it appears 
an association exists, nonetheless.  Because asthma seems to be exacerbated by 
gastroesophageal reflux, treating the reflux appears to be an effective means of 
improving or relieving asthma symptoms and reducing the need for control medication 
in those patients with both conditions.  Each of the three studies reviewed, revealed 
improvement of asthma in some form or another.  A significant portion of patients 
reported improvement of asthma symptoms following fundoplication.  Not only did the 
patients who underwent antireflux surgery experience a higher rate of improvement over 
those taking antireflux medication, but they also experienced those improvements 
almost immediately and continued to maintain their improved or relieved state, rather 
than regressing at any period of time as did many in the medication groups.  A great 
number of patients were also able to reduce or completely discontinue use of some or 
all of their asthma medications.  The most impressive outcome from fundoplication in 
terms of medication reduction or elimination was that some patients no longer needed 
to take oral corticosteroids to manage their airways.  Spivak et al. (1999) reported that, 
overall, 73 percent of the surgical patients were able to reduce their corticosteroid use. 
This is substantial for those who have been on or will need to be on systemic steroids 
long-term due to their long-term affects.  Though these results seem very promising, 
this study was limited by its sample size due to the nature of the Nissen procedure 
being primarily for GERD and generally not for the primary indication of asthma, which 
is the population this study was following.  Only 39 of the 600 patients who had 
undergone fundoplication were doing so principally for asthma. 
 The theory that GERD-induced asthma is partially caused by microaspiration of 
reflux, whether symptomatic or not, has implications for long-term airway remodeling.   
The medication groups in all three studies did not show much improvement in asthma 
symptoms scores or medication use.  Moreover, they did not show much improvement 
in GERD symptoms score, either.  It is believed that, while acid-inhibiting medication 
may reduce or neutralize the acid, there is still refluxate migrating up the esophagus 
that is being aspirated due to an incompetent lower esophageal sphincter (LES), 
causing irritation to the airways.  This, over time, can lead to airway remodeling, causing 
even further progression and exacerbation the patient’s asthma.  The only way to 
prevent any microaspiration of reflux is to definitively eliminate the cause of refluxate.  
Fundoplication does this by increasing the LES pressure and restoring a reflux barrier.  
 When considering the GRADE criteria for evaluating outcomes, there were four 
outcomes that were similar among two or more studies.  Frequency of exacerbations, 
including wheezing and coughing, were reduced in two studies, although the quality of 
evidence is low.  Nocturnal asthma symptoms improved throughout two studies, and 
evidence of such proved to be of moderate quality.  The need for control medication 
was reduced across two of the studies.  These medications included inhaled 
bronchodilators, oral bronchodilators, and inhaled corticosteroids.  One study yielded 
high quality evidence and the other yielded low quality evidence for a moderate overall 
GRADE strength.  Oral corticosteroids were given their own outcome category.  This 
outcome is one of the most considerable of all outcomes due to its implications that one 
can reduce, or eliminate outright, the need for systemic steroids.  Two studies that 
specifically addressed oral corticosteroid use showed a reduced need for such 
medication, with one study showing a statistically significant reduction in use.  The 
outcome qualities for oral corticosteroid use were moderate and high, respectively, for 
an overall evidence strength of moderate.  The evidence in support of fundoplication for 
improvement or relief of asthma symptoms or need for asthma medication, as 
determined by GRADE criteria, is of moderate quality based on the three studies in this 
review (Appendix A).  By definition from the GRADE working group, evidence of 
moderate quality implies further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate.   
 Generally speaking, studies looking at fundoplication success for the primary 
indication of asthma, will be limited in sample size because this is mainly a procedure 
indicated for GERD, and there are far fewer patients electing this procedure with 
asthma or respiratory symptoms as their foremost complaint, making it challenging to 
assess outcomes that are largely based on respiratory symptoms.  What is known, is 
that fundoplication is the single most effective treatment for acid reflux, with 90 percent 
of patients reporting cure or significant improvement after the procedure (Patti, 2000).  
One should confidently be able to conclude that, if GERD exacerbates or potentially 
causes some asthma, the best treatment for GERD-induced asthma would be to cure 
the GERD and effectively eliminate the very cause of the hyper-reactive airway. 
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*ROS- retrospective observational study 
** RCT- Randomized control trial  
^Cough and wheeze associated with reflux symptoms occurring within three minutes of onset of reflux 
 
 
 
 
 
 
